BIORESTORATIVE THERAPI
1.5750
08-11月-24 14:03:24
15 分の遅延
株式
+0.0150
+0.96%
本日の幅
1.5500 - 1.6500
ISIN
N/A
ソース
NASDAQ
-
BioRestorative Therapies to Seek FDA Approval to Expand the Clinical Application of BRTX-100
13 3 2023 06:00:00 提供 Nasdaq GlobeNewswire
-
BioRestorative Therapies to Participate at the 35th Annual ROTH MKM Conference on March 12 -14, 2023
07 3 2023 05:30:00 提供 Nasdaq GlobeNewswire
-
02 3 2023 06:30:00 提供 Nasdaq GlobeNewswire
-
08 2 2023 08:00:01 提供 Nasdaq GlobeNewswire
-
06 12 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
29 11 2022 10:20:00 提供 Nasdaq GlobeNewswire
-
16 11 2022 07:56:00 提供 Nasdaq GlobeNewswire
-
BioRestorative Therapies CEO Lance Alstodt to be Interviewed on Famela and Friends Talk Radio Show
20 10 2022 08:30:00 提供 Nasdaq GlobeNewswire
-
28 9 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference
27 9 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
07 9 2022 06:00:02 提供 Nasdaq GlobeNewswire
-
30 6 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
22 6 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
13 6 2022 06:00:00 提供 Nasdaq GlobeNewswire
-
29 4 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
18 4 2022 07:00:00 提供 Nasdaq GlobeNewswire
-
BioRestorative Therapies Announces cGMP Cell Manufacturing Facility Certification
04 4 2022 07:00:02 提供 Nasdaq GlobeNewswire
-
10 3 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
BioRestorative Therapies Announces Notice of Allowance on Key Patent for its BRTX-100® Disc Program
16 2 2022 07:30:00 提供 Nasdaq GlobeNewswire